Completed Lungs & Breathing NIHR-supported project Cancer
A phase 3b open label, single arm study to assess the effect of depemokimab on airway structure and function in asthma with an eosinophilic phenotype utilising quantitative high-resolution CT and bronchoscopic airway sampling: the IMAGINE study
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Hitasha Rupani (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
A Phase 2a, open label, two-part study to evaluate the mechanism of action of itepekimab (anti-IL-33 mAb) on airway inflammation in patients with chronic obstructive pulmonary disease (COPD)
AERIFY 3 - A Phase 2a, open-label, two-part study to evaluate the mechanism of action of itepekimab (anti-IL-33 mAb) on airway inflammation in patients with chronic obstructive pulmonary disease (COPD)
A Phase 2a, open-label, two-part study to evaluate the mechanism of action of itepekimab (anti-IL-33 mAb) on airway inflammation in patients with chronic obstructive pulmonary disease (COPD)
A randomised, double-blind, placebo-controlled, parallel-group, Proof-of-Concept (PoC) study to assess the efficacy, safety and tolerability of Itepekimab, in participants with non-cystic fibrosis bronchiectasis
A randomized, double blind, placebo-controlled, parallel-group, Proof-of-Concept (PoC) study to assess, the efficacy, safety and tolerability of Itepekimab, in participants with non-cystic fibrosis bronchiectasis
Original classification
Respiratory and Allergy (RA)Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know